Journal profile · Agricultural and Biological Sciences-Food Science

The EuroBiotech Journal

ISSN 2564-615X · Sciendo · Poland

The EuroBiotech Journal: CAS Zone 4 · Multidisciplinary (2025 upgraded edition); impact factor 13 (journal website); diamond open access (no APC); no APC; review about 10 weeks (community reports); 22 articles in 2025; indexed in Scopus.

Impact factor13From the journal's website, latest value
CAS zoneZone 4 · Multidisciplinary2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Multidisciplinary
Review timeabout 10 weeksCommunity average
APCNo APCDiamond open access (no APC)
Acceptance—No reports yet
Articles per year222025 · OpenAlex count

Scope

Aims, scope and focus

The EuroBiotech Journal is the official journal of the The European Biotechnology Thematic Network Association (EBTNA) and is published periodically every three months. It covers both the science of biotechnology. The journal publishes peer-reviewed research articles, reviews, brief reports, short communications and opinions in various areas of biotechnology. The EuroBiotech Journal presents the full diversity of biotechnology science, particularly advances in research and developments that open opportunities for exploitation of knowledge, commercially or otherwise, together with discussion and comment on broader issues of general interest and concern. The outlook is fully international.The scope of the EuroBiotech Journal includes the research and industrial aspects of biotechnology, in areas including: Healthcare and Pharmaceuticals; Immunotherapy and Diagnostics; Genetic Engineering; Gene-Editing; Protein Engineering; Genomics; Synthetic Biology; Molecular technologies; Nanotechnology; Bioinformatics and Databases; and Digital technologies and Artificial Intelligence, where they relate to biotechnology.The EuroBiotech Journal publishes only online, and all articles are available on our website free of charge. Each work will receive a unique DOI (Digital Object Identifier) number.The EuroBiotech Journal is committed to publishing works in the field of biotechnology by researchers from all over the World which are innovative and contribute to scientific knowledge.

From the journal's Aims & Scope

Research area (LetPub): Agricultural and Biological Sciences-Food Science

Editor-in-chief Munis DundarPublisher website

Editorial board by country: 2 in mainland China (about 4%); most named Türkiye 13, Italy 10, United States 5, France 3, Mainland China 2 (54 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Retinal Development and DisordersBiochemistry, Genetics and Molecular Biology9.6%
  2. Retinal Diseases and TreatmentsMedicine8.1%
  3. Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences5.7%
  4. Probiotics and Fermented FoodsAgricultural and Biological Sciences5.3%
  5. CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology4.8%
  6. Plant tissue culture and regenerationBiochemistry, Genetics and Molecular Biology4.3%
  7. Microbial Metabolic Engineering and BioproductionBiochemistry, Genetics and Molecular Biology4.3%
  8. Plant Stress Responses and ToleranceAgricultural and Biological Sciences3.8%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Multidisciplinary Zone 4
LevelCategoryZone
MajorMultidisciplinaryZone 4
MinorMultidisciplinary SciencesZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Multidisciplinary Zone 4
LevelCategoryZone
MajorMultidisciplinaryZone 4
MinorMultidisciplinary SciencesZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
13Publisher website ·
CiteScore 2026-06
2LetPub ·
CiteScore (publisher)
20Publisher website ·
SJR 2026-06
0.25LetPub ·
SNIP 2026-06
0.28LetPub ·
h-index
21OpenAlex ·
i10-index
46OpenAlex ·
2-year mean citedness
1.77OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 333 in total · the current year is incomplete

YearArticlesOpen accessCitations
202619192
2025222227
2024212181
20231919169
2022171763
20213232209

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 10 weeksLetPub ·
Submission to publication (journal-reported)
about 10 weeksDOAJ ·
Peer review
Unspecified peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Diamond open access (no APC)DOAJ

Every article is open access and authors pay no article processing charge.

SourceAPCFee waiverLicenseObserved
DOAJNo APCNoCC BY-NC-ND
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Policy excerpts from the journal's websiteLicense & copyright
License & copyright Copyright 2026 © Paradigm. All rights reserved.

Currency:EUR €USD $GBP £ Terms of servicePrivacy policyEthical policiesAccessibility

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Sciendo
Country or region
Poland
Language
English
ISSN
2564-615X
Society / sponsor
The European Biotechnology Thematic Network Association
Official links

FAQ

Frequently asked questions about The EuroBiotech Journal

What CAS zone is The EuroBiotech Journal in?

In the 2025 upgraded edition of the CAS Journal Ranking, The EuroBiotech Journal is in Zone 4 of Multidisciplinary, and in Zone 4 of the minor category Multidisciplinary Sciences. In the 2026 Xinrui edition it is in Zone 4 of Multidisciplinary. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of The EuroBiotech Journal?

The journal's website gives an impact factor of 13; this is the journal's own figure, as LetPub lists none for it; CiteScore 2, h-index 21.

How long does peer review take at The EuroBiotech Journal?

Authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of The EuroBiotech Journal based?

Of the 54 board members whose country the journal's board page names, 2 (about 4%) are in mainland China; the countries named most often are Türkiye (13), Italy (10) and United States (5). Counted from the institutions listed on the board page; for reference only.

Which databases index The EuroBiotech Journal?

According to LetPub and DOAJ records, The EuroBiotech Journal is indexed in Scopus and DOAJ.

Is The EuroBiotech Journal open access, and what is the APC?

The EuroBiotech Journal is a diamond open-access journal (no APC). It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .